Kidneys, one of the most important organs in our body, carry out the important task of discarding waste and extra fluids from ...

Updated recommendations for antiretroviral nonoccupational postexposure prophylaxis (nPEP) for HIV have been published in the ...

Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Compound Annual Growth ...

Persons initiating nPEP should be informed that preexposure prophylaxis (PrEP) can reduce their risk for acquiring HIV in the case of repeat or continuing exposure after the nPEP course.

Patients with HIV can take both their antiretroviral therapy (ART) and treatment to prevent tuberculosis safely to prevent ...

Atea defines working capital as current assets less current liabilities. See the Company's condensed consolidated financial ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Biktarvy is an HIV treatment that includes the three ingredients bictegravir, emtricitabine and tenofovir alafenamide. "Biktarvy isn't just a leading HIV treatment — it's the financial backbone ...

A new commentary published in Annals of Internal Medicine from Roy Gulick, MD, Chief, Division of Infectious Diseases and ...

Key Takeaways Drugs used to inhibit HIV and hepatitis B might help deter Alzheimer’s diseaseNucleoside reverse transcriptase ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...